{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:00:12Z","timestamp":1785787212617,"version":"3.56.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1097\/01.mcg.0000124026.92823.fc","type":"journal-article","created":{"date-parts":[[2004,4,27]],"date-time":"2004-04-27T04:00:29Z","timestamp":1083038429000},"page":"S51-S56","source":"Crossref","is-referenced-by-count":27,"title":["Do Serological Markers and Cytokines Determine the Indeterminate?"],"prefix":"10.1097","volume":"38","author":[{"given":"Scott","family":"Plevy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210309","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jama.1984.03340250053024","article-title":"Landmark article Oct 15, 1932. Regional ileitis: a pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer.","volume":"251","author":"Crohn","year":"1984","journal-title":"JAMA"},{"key":"R2-14-20210309","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00004836-198806000-00012","article-title":"Historical aspects of inflammatory bowel disease.","volume":"10","author":"Kirsner","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"R3-14-20210309","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/jaut.1999.0340","article-title":"Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA.","volume":"14","author":"Eggena","year":"2000","journal-title":"J Autoimmun"},{"key":"R4-14-20210309","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1128\/IAI.67.12.6510-6517.1999","article-title":"Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohns disease.","volume":"67","author":"Cohavy","year":"1999","journal-title":"Infect Immun"},{"key":"R5-14-20210309","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/clim.1999.4805","article-title":"Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies.","volume":"94","author":"Gordon","year":"2000","journal-title":"Clin Immunol"},{"key":"R6-14-20210309","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1023203118100","article-title":"pANCA represents a cross-reactivity to enteric bacterial antigens.","volume":"18","author":"Seibold","year":"1998","journal-title":"J Clin Immunol"},{"key":"R7-14-20210309","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1995.tb03836.x","article-title":"Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD).","volume":"102","author":"Duchmann","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"R8-14-20210309","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/eji.1830260432","article-title":"Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.","volume":"26","author":"Duchmann","year":"1996","journal-title":"Eur J Immunol"},{"key":"R9-14-20210309","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1128\/IAI.69.4.2277-2285.2001","article-title":"Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.","volume":"69","author":"Rath","year":"2001","journal-title":"Infect Immun"},{"key":"R10-14-20210309","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/gut.52.12.1721","article-title":"Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice.","volume":"52","author":"Hoentjen","year":"2003","journal-title":"Gut"},{"key":"R11-14-20210309","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","article-title":"Selected loss of tolerance evidenced by Crohns disease-associated immune responses to auto- and microbial antigens.","volume":"123","author":"Landers","year":"2002","journal-title":"Gastroenterology"},{"key":"R12-14-20210309","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4049\/jimmunol.159.1.44","article-title":"Spontaneously colitic C3H\/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora.","volume":"159","author":"Brandwein","year":"1997","journal-title":"J Immunol"},{"key":"R13-14-20210309","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-3083.2001.00857.x","article-title":"Elevated antibody responses in patients with Crohns disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis.","volume":"53","author":"Olsen","year":"2001","journal-title":"Scand J Immunol"},{"key":"R14-14-20210309","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/gast.2000.8519","article-title":"Identification of a novel bacterial sequence associated with Crohns disease.","volume":"119","author":"Sutton","year":"2000","journal-title":"Gastroenterology"},{"key":"R15-14-20210309","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1128\/IAI.70.12.6567-6575.2002","article-title":"Pseudomonas fluorescens encodes the Crohns disease-associated I2 sequence and T-cell superantigen.","volume":"70","author":"Wei","year":"2002","journal-title":"Infect Immun"},{"key":"R16-14-20210309","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/bega.2002.0347","article-title":"Serological markers in inflammatory bowel diseases.","volume":"17","author":"Reumaux","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R17-14-20210309","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0140-6736(00)03488-7","article-title":"Serological diagnosis of inflammatory bowel disease.","volume":"356","author":"Rutgeerts","year":"2000","journal-title":"Lancet"},{"key":"R19-14-20210309","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00054725-200108000-00003","article-title":"Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohns disease.","volume":"7","author":"Sandborn","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"R20-14-20210309","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.","volume":"96","author":"Peeters","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R21-14-20210309","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.","volume":"42","author":"Quinton","year":"1998","journal-title":"Gut"},{"key":"R22-14-20210309","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0016-5085(98)70252-5","article-title":"Diagnostic accuracy of serologic assays in pediatric inflammatory bowel disease.","volume":"115","author":"Ruemmele","year":"1998","journal-title":"Gastroenterology"},{"key":"R23-14-20210309","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gut.47.4.487","article-title":"Marker antibody expression stratifies Crohns disease into immunologically homogeneous subgroups with distinct clinical characteristics.","volume":"47","author":"Vasiliauskas","year":"2000","journal-title":"Gut"},{"key":"R24-14-20210309","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1053\/gast.1996.v110.pm8964407","article-title":"Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohns disease define a clinical subgroup.","volume":"110","author":"Vasiliauskas","year":"1996","journal-title":"Gastroenterology"},{"key":"R25-14-20210309","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4065\/71.5.431","article-title":"Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study.","volume":"71","author":"Sandborn","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"R26-14-20210309","first-page":"740","article-title":"Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis.","volume":"90","author":"Sandborn","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"R27-14-20210309","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0167-5699(93)90044-L","article-title":"Cytokine regulation of T-cell function: potential for therapeutic intervention.","volume":"14","author":"Powrie","year":"1993","journal-title":"Immunol Today"},{"key":"R28-14-20210309","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jlb.67.3.267","article-title":"Insights from mouse models of colitis.","volume":"67","author":"Boismenu","year":"2000","journal-title":"J Leukoc Biol"},{"key":"R29-14-20210309","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1096\/fj.99-0885hyp","article-title":"Does the failure to acquire helminthic parasites predispose to Crohns disease?","volume":"14","author":"Elliott","year":"2000","journal-title":"FASEB J"},{"issue":"suppl","key":"R30-14-20210309","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/ajrccm.162.supplement_3.15tac7","article-title":"Oral tolerance.","volume":"162","author":"Smith","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-14-20210309","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0923-2494(98)80154-5","article-title":"Responses to self and non-self intestinal microflora in health and inflammatory bowel disease.","volume":"148","author":"Duchmann","year":"1997","journal-title":"Res Immunol"},{"key":"R32-14-20210309","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0016-5085(97)70116-1","article-title":"Distinct cytokine patterns in early and chronic ileal lesions of Crohns disease.","volume":"113","author":"Desreumaux","year":"1997","journal-title":"Gastroenterology"},{"key":"R33-14-20210309","first-page":"11","article-title":"Measurement of tumor necrosis factor alpha mRNA in small numbers of cells by quantitative polymerase chain reaction.","volume":"5","author":"Andus","year":"1993","journal-title":"Reg Immunol"},{"key":"R34-14-20210309","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.4049\/jimmunol.159.12.6276","article-title":"A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohns disease.","volume":"159","author":"Plevy","year":"1997","journal-title":"J Immunol"},{"key":"R35-14-20210309","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2003.50019","article-title":"Crohns disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.","volume":"124","author":"Bonen","year":"2003","journal-title":"Gastroenterology"},{"key":"R36-14-20210309","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1074\/jbc.C200651200","article-title":"Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.","volume":"278","author":"Girardin","year":"2003","journal-title":"J Biol Chem"},{"key":"R37-14-20210309","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohns disease.","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"R38-14-20210309","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohns disease.","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"R39-14-20210309","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/339432","article-title":"CARD15\/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.","volume":"70","author":"Lesage","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R40-14-20210309","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0140-6736(02)08590-2","article-title":"Association of NOD2 (CARD 15) genotype with clinical course of Crohns disease: a cohort study.","volume":"359","author":"Hampe","year":"2002","journal-title":"Lancet"},{"key":"R41-14-20210309","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/gast.2002.32415","article-title":"The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.","volume":"122","author":"Cuthbert","year":"2002","journal-title":"Gastroenterology"},{"key":"R42-14-20210309","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/gast.2002.35393","article-title":"Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohns disease.","volume":"123","author":"Abreu","year":"2002","journal-title":"Gastroenterology"},{"key":"R43-14-20210309","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.52.8.1133","article-title":"Genotype-phenotype analysis of the Crohns disease susceptibility haplotype on chromosome 5q31.","volume":"52","author":"Armuzzi","year":"2003","journal-title":"Gut"},{"key":"R44-14-20210309","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1053\/gast.2002.34172","article-title":"NOD2\/CARD15 does not influence response to infliximab in Crohns disease.","volume":"123","author":"Vermeire","year":"2002","journal-title":"Gastroenterology"},{"key":"R45-14-20210309","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/gast.2001.23966","article-title":"ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohns disease.","volume":"120","author":"Taylor","year":"2001","journal-title":"Gastroenterology"},{"key":"R46-14-20210309","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/gas.37.7.818.824","article-title":"A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism.","volume":"37","author":"Louis","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"R47-14-20210309","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","article-title":"The value of serologic markers in indeterminate colitis: a prospective follow-up study.","volume":"122","author":"Joossens","year":"2002","journal-title":"Gastroenterology"},{"key":"R49-14-20210309","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00000658-200006000-00017","article-title":"Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis.","volume":"231","author":"Farouk","year":"2000","journal-title":"Ann Surg"},{"key":"R50-14-20210309","first-page":"2","article-title":"Complications after ileal pouch-anal anastomosis.","volume":"11","author":"Stein","year":"2000","journal-title":"Semin Gastrointest Dis"},{"key":"R51-14-20210309","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.49.5.671","article-title":"High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis.","volume":"49","author":"Fleshner","year":"2001","journal-title":"Gut"},{"key":"R52-14-20210309","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2249.1990.tb03334.x","article-title":"Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.","volume":"81","author":"MacDonald","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"R53-14-20210309","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/jcp.47.11.1015","article-title":"Decreased mucosal interleukin-4 (IL-4) production in gut inflammation.","volume":"47","author":"Karttunnen","year":"1994","journal-title":"J Clin Pathol"},{"key":"R54-14-20210309","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2036.2003.01686.x","article-title":"Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study.","volume":"18","author":"Gornet","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R55-14-20210309","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2036.2003.01739.x","article-title":"Infliximab in the treatment of medically refractory indeterminate colitis.","volume":"18","author":"Papadakis","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R56-14-20210309","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1053\/gast.2001.28017","article-title":"The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis.","volume":"121","author":"Carter","year":"2001","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mcg.0000124026.92823.fc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:05:24Z","timestamp":1785783924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-200405001-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":54,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mcg.0000124026.92823.fc","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}